Jardiance vs. Glipizide

See how Jardiance and Glipizide compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Jardiance is an SGLT2 inhibitor with added heart and kidney benefits, while Glipizide is a sulfonylurea used only for blood sugar control.

  • Jardiance is taken once daily with no titration, while Glipizide often requires dose adjustments to find the right amount.

  • Glipizide costs far less per month than Jardiance, but carries a higher risk of hypoglycemia.

Jardiance vs. Glipizide Drug Summary

Jardiance

Jardiance (empagliflozin) is an SGLT2 inhibitor that lowers blood sugar by causing the kidneys to remove excess glucose through urine. It's taken as one tablet by mouth once a day with no dose titration required. Beyond diabetes, it's approved to reduce cardiovascular death, heart failure hospitalization, and kidney disease progression.

Glipizide

Glipizide is a sulfonylurea that lowers blood sugar by prompting the pancreas to release more insulin. It's taken as an immediate-release tablet once or twice daily, or an extended-release tablet once daily, with doses adjusted over time. It's approved only for blood sugar control in type 2 diabetes, alongside diet and exercise.

Jardiance vs. Glipizide Side Effects

Jardiance

Most common
hypoglycemia (up to 41.3%)
volume depletion (up to 11.4%)
urinary tract infection (up to 9.3%)
genital yeast infection (up to 5.4%)

Glipizide

Most common
dizziness (up to 2%)
drowsiness (up to 2%)
headache (up to 2%)
nausea (up to 1.4%)

Jardiance vs. Glipizide Dosage

Jardiance

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily At the start
Maximum dose 25 mg once daily If needed
Dose changes 1 increase As tolerated

Glipizide

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 5 mg once daily At the start
Maximum dose 5-20 mg once daily If needed
Dose changes 5 increases As tolerated

Jardiance vs. Glipizide Indications

Jardiance

Jardiance treats type 2 diabetes and carries several approvals beyond glucose control, including heart failure and chronic kidney disease. It's often chosen for patients who need cardiovascular or kidney protection in addition to blood sugar management.

  • Blood sugar control in adults and children 10+ with type 2 diabetes

  • Reduce cardiovascular death risk in adults with type 2 diabetes and heart disease

  • Reduce cardiovascular death and hospitalization in heart failure

Glipizide

Glipizide is approved only for blood sugar control in adults with type 2 diabetes, used alongside diet and exercise. It carries no cardiovascular or kidney-protection approvals.

  • Blood sugar control in adults with type 2 diabetes

  • Used as an adjunct to diet and exercise

  • Available in immediate-release and extended-release forms

Jardiance vs. Glipizide Pros and Cons

Jardiance

Jardiance offers added cardiovascular and kidney benefits beyond glucose control, with simple once-daily dosing and no titration. It carries risks of genital infections and volume depletion, and it costs significantly more than older generic options.

Pros

  • One pill, once a day, no dose adjustments needed

  • Reduces risk of cardiovascular death and heart failure hospitalization

  • Slows progression of chronic kidney disease

Cons

  • Can cause genital yeast infections and urinary tract infections

  • Risk of dehydration and low blood pressure, especially in older adults

  • Rare risk of diabetic ketoacidosis even without high blood sugar

  • Roughly $350 to $620 per month without insurance, before savings programs

Glipizide

Glipizide is inexpensive and has decades of clinical use behind it, but it requires more careful titration and carries meaningful hypoglycemia risk in older or frail patients. It also lacks any cardiovascular or kidney-protective benefit.

Pros

  • Roughly $10 to $35 per month, one of the cheapest diabetes pills

  • Decades of real-world use and prescribing experience

  • Available in extended-release form for once-daily dosing

Cons

  • Higher risk of hypoglycemia, especially in older or frail patients

  • Requires dose titration over multiple visits to find the right amount

  • No cardiovascular or kidney protection benefits

  • Class linked to a possible cardiovascular mortality signal in older studies

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.